CHST9 and metastatic malignant neoplasm in the lymph nodes: Among the TNBC patients without lymph-node metastasis, the mean DFS of the CHST9 rs1436904 GG genotype was significantly shorter than that of the TT genotype patients (48.1 months vs. 62.6 months; P = 0.033) (Table 2 and Fig. 3).